Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists

Bioorg Med Chem Lett. 2013 Mar 15;23(6):1865-9. doi: 10.1016/j.bmcl.2013.01.002. Epub 2013 Jan 23.

Abstract

We describe an efficient synthesis of metabolically stabilized sn-2 radyl phosphorothioate analogs of lysophosphatidic acid (LPA), and the determination of the agonist activity of each analog for the six LPA receptors (LPA1-6) using a recently developed TGFα shedding assay. In general, the sn-2 radyl OMPT analogs showed similar agonist activities to the previous 1-oleoyl-2-O-methyl-glycerophosphothioate (sn-1 OMPT) analogs for LPA1-6 receptors. In most cases, the sn-2 radyl-OMPT analogs were more potent agonists than LPA itself. Most importantly, sn-2 alkyl OMPT analogs were very potent LPA5 and LPA6 agonists. The availability of sn-2 radyl OPMT analogs further refines the structure-activity relationships for ligand-receptor interactions for this class of GPCRs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / metabolism
  • HEK293 Cells
  • Humans
  • Lysophospholipids / chemistry*
  • Phosphates / chemical synthesis
  • Phosphates / chemistry*
  • Phosphates / metabolism
  • Protein Binding
  • Protein Isoforms / agonists
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Receptors, Lysophosphatidic Acid / agonists*
  • Receptors, Lysophosphatidic Acid / genetics
  • Receptors, Lysophosphatidic Acid / metabolism
  • Structure-Activity Relationship
  • Transforming Growth Factor alpha / metabolism

Substances

  • Lysophospholipids
  • Phosphates
  • Protein Isoforms
  • Receptors, Lysophosphatidic Acid
  • Transforming Growth Factor alpha
  • Alkaline Phosphatase
  • lysophosphatidic acid
  • thiophosphoric acid